NCT06145945View on ClinicalTrials.gov

Effect of Intraperitoneal Ropivacaine on Visceral Pain After Laparoscopic Gastrectomy

NANot yet recruitingINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

November 25, 2023

Primary Completion Date

March 3, 2024

Study Completion Date

July 7, 2024

Conditions
Laparoscopic GastrectomyRopivacaine
Interventions
DRUG

0.5% Ropivacaine

20ml 0.5% ropivacaine is sprayed intraperitoneally

DRUG

Saline

20ml saline is sprayed intraperitoneally

Trial Locations (1)

Unknown

SanQing Jin, Guangzhou

All Listed Sponsors
lead

SanQing Jin

OTHER

NCT06145945 - Effect of Intraperitoneal Ropivacaine on Visceral Pain After Laparoscopic Gastrectomy | Biotech Hunter | Biotech Hunter